Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

InVivo Therapeutics Holdings buy DomRuinart

Start price
€36.75
25.01.21 / 50%
Target price
€50.00
25.01.22
Performance (%)
-12.24%
End price
€32.25
08.02.21
Summary
This prediction ended on 08.02.21 with a price of €32.25. The prediction for InVivo Therapeutics Holdings disappointed with a performance of -12.24%. DomRuinart has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
InVivo Therapeutics Holdings -18.678% -18.678% -76.925% -99.961%
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

According to DomRuinart what are the pros and cons of InVivo Therapeutics Holdings for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by DomRuinart for this prediction

In the thread Invivo Therapeutics diskutieren
Prediction Buy
Perf. (%) -12.24%
Target price 2.000
Change
Ends at 25.01.22

Buy mit Kursziel 2,0

In the thread Trading InVivo Therapeutics Holdings
Prediction Buy
Perf. (%) -12.24%
Target price 2.000
Change
Ends at 25.01.22

Buy beendet

Stopped prediction by DomRuinart for InVivo Therapeutics Holdings

buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€32.25
08.02.21
€50.00
08.02.22
6.98%
22.02.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€22.25
11.01.21
€75.00
11.01.22
65.17%
25.01.21

Could be worthwhile Investment >10% per year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€13.00
14.12.20
€25.00
14.12.21
71.15%
11.01.21

Could be worthwhile Investment >10% per year